Showing results (1831-1840 of 6,713) with videos related to

Sort By:
Pageof 672
Oncotargets and Therapy|April 5, 2016
miR-98 functions as a tumor suppressor in salivary adenoid cystic carcinomasXiaonan Liu, Wenchao Zhang, Hua Guo, et al.
Oncotargets and Therapy|May 27, 2016
Upregulation of nucleostemin in colorectal cancer and its effects on cell malignancy [Retraction]
Oncotargets and Therapy|July 26, 2017
Conventional real-time PCR-based detection of T790M using tumor tissue or blood in patients with EGFR TKI-resistant NSCLCYa-Lan Wu, Rui-Zhan Tong, Yan Zhang, et al.
Oncotargets and Therapy|July 26, 2017
Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3-4 nasopharyngeal carcinomaFen Xue, Chaosu Hu, Xiayun He
Oncotargets and Therapy|July 27, 2017
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinibHampig Raphael Kourie, Elie El Rassy, Florian Clatot, et al.
Oncotargets and Therapy|July 27, 2017
Prognostic role of lymphocyte to monocyte ratio for patients with pancreatic cancer: a systematic review and meta-analysisWendi Li, Lianyuan Tao, Lingfu Zhang, et al.
Oncotargets and Therapy|July 27, 2017
A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinomaHai-Wei Liang, Zhi-Hua Ye, Shu-Ya Yin, et al.
Oncotargets and Therapy|August 10, 2017
Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancerL E Dockery, C C Gunderson, K N Moore
Oncotargets and Therapy|August 10, 2017
The association between SPINK1 and clinical outcomes in patients with prostate cancer: a systematic review and meta-analysisXingming Zhang, Xiaoxue Yin, Pengfei Shen, et al.
Oncotargets and Therapy|August 10, 2017
Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancerLei Shen, Xiaoguang Wu, Jinjing Tan, et al.
Pageof 672